More recent work has shown that pharicin A, a natural diterpenoid, which might act as an ATP-competitive inhibitor [66], can induce mitotic arrest of paclitaxel-sensitive and -resistant tumor cells through the inhibition of BUBR1 activity [66]. This evidence concerns the gene BUB1B and neoplasm.